2007 Heart-Brain summit proceedings
BAKKEN LECTURE:
Depression in coronary artery disease:
Does treatment help?
ABSTRACT
Research over the past decade on the link between depression and coronary artery disease (CAD) has moved from establishing the epidemiologic association between depression and CAD to a focus on whether and how treating depression in patients with CAD benefits these patients. Evidence to date indicates that depression therapy does improve depression, albeit somewhat modestly, in CAD patients. The effect of depression therapy on CAD outcomes is less clear, although there is enough positive evidence to encourage further research. The effects of depression treatment on mechanisms mediating increased CAD risk in depressed patients are variable. Future research should perhaps focus on targeting treatment at intermediary mechanisms as well as at depression itself.
CITATIONS
- Review Panel on Coronary-Prone Behavior and Coronary Heart Disease.
Coronary-prone behavior and coronary heart disease: a critical review. Circulation 1981; 63:1199–1215.
http://www.ncbi.nlm.nih.gov/pubmed/7014026 - Friedman M, Thoresen CE, Gill JJ, et al.
Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project. Am Heart J 1986; 112:653–665.
http://www.ncbi.nlm.nih.gov/pubmed/3766365 - Booth-Kewley S, Friedman HS.
Psychological predictors of heart disease: a quantitative review. Psychol Bull 1987; 101:343–362.
http://www.ncbi.nlm.nih.gov/pubmed/3602244 - Glassman AH, Shapiro PA.
Depression and the course of coronary artery disease. Am J Psychiatry 1998; 155:4–11.
http://www.ncbi.nlm.nih.gov/pubmed/9433332 - Ariyo AA, Haan M, Tangen CM, et al.
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 2000; 102:1773–1779.
http://www.ncbi.nlm.nih.gov/pubmed/11023931 - Penninx BWJH, Beekman ATF, Honig A, et al.
Depression and cardiac mortality. Results from a community-based longitudinal study. Arch Gen Psychiatry 2001; 58:221–227.
http://www.ncbi.nlm.nih.gov/pubmed/11231827 - Penninx BWJH, Geerlings SW, Deeg dJH, van Eijk JTM, van Tilburg W, Beekman ATF.Minor and major depression and the risk
of death in older persons. Arch Gen Psychiatry 1999; 56:889–895.
http://www.ncbi.nlm.nih.gov/pubmed/10530630 - Rosengren A, Hawken S, Ôunpuu S, et al.
Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:953–962.
http://www.ncbi.nlm.nih.gov/pubmed/15364186 - Frasure-Smith N, Lesperance F, Talajic M.
Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270:1819–1825.
http://www.ncbi.nlm.nih.gov/pubmed/8411525 - Frasure-Smith N, Lesperance F, Talajic M.
Depression and 18- month prognosis following myocardial infarction. Circulation 1995; 91:999–1005.
http://www.ncbi.nlm.nih.gov/pubmed/7531624 - Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP.
Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study.Lancet 2001; 358:1766–1771.
http://www.ncbi.nlm.nih.gov/pubmed/11734233 - Blumenthal JA, Lett HS, Babyak MA, et al.
Depression as a risk factor for mortality after coronary artery bypass surgery.Lancet 2003; 362:604–609.
http://www.ncbi.nlm.nih.gov/pubmed/12944059 - Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG.
Fiveyear risk of cardiac mortality in relation to initial severity and oneyear changes in depression symptoms after myocardial infarction. Circulation 2002; 105:1049–1053.
http://www.ncbi.nlm.nih.gov/pubmed/11877353 - Musselman DL, Evans DL, Nemeroff CB.
The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 1998; 55:580–592.
http://www.ncbi.nlm.nih.gov/pubmed/9672048 - Schleifer SJ, Macari-Hinson MM, Coyle DA, et al.
The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149:1785–1789.
http://www.ncbi.nlm.nih.gov/pubmed/2788396 - Hance M, Carney RM, Freedland KE, Skala J.
Depression in patients with coronary heart disease. Gen Hosp Psychiatry 1996; 18:61–65.
http://www.ncbi.nlm.nih.gov/pubmed/8666215 - Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, WhooleyMA.
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003; 290:215–221.
http://www.ncbi.nlm.nih.gov/pubmed/12851276 - Giardina EG, Barnard T, Johnson L, Saroff AL, Bigger JT Jr, Louie M.
The antiarrhythmic effect of nortriptyline in cardiac patients with premature ventricular depolarizations. J Am Coll Cardiol 1986; 7:1363–1369.
http://www.ncbi.nlm.nih.gov/pubmed/3711494 - Giardina EGV, Cooper TB, Suckow R, et al.
Cardiovascular effects of doxepin in cardiac patients with ventricular arrhythmias. Clin Pharmacol Ther 1987; 42:20–27.
http://www.ncbi.nlm.nih.gov/pubmed/3595065 - Glassman AH, Rodriguez AI, Shapiro PA.
The use of antidepressant drugs in patients with heart disease. J Clin Psychiatry 1998; 59(Suppl 10):16–21.
http://www.ncbi.nlm.nih.gov/pubmed/9720478 - Glassman AH, Roose SP, Bigger JT Jr.
The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 1993; 269:2673–2675.
http://www.ncbi.nlm.nih.gov/pubmed/8487453 - Roose SP, Glassman AH, Dalack GW.
Depression, heart disease, and tricyclic antidepressants. J Clin Psychiatry 1989; 50(Suppl):12–16.
http://www.ncbi.nlm.nih.gov/pubmed/2661547 - Roose SP, Glassman AH, Giardina EGV, et al.
Nortriptyline in depressed patients with left ventricular impairment. JAMA 1986; 256:3253–3257.
http://www.ncbi.nlm.nih.gov/pubmed/3783871 - Roose SP, Glassman AH, Giardina EGV, Walsh BT, Woodring S, Bigger JT.
Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 1987; 44:273–275.
http://www.ncbi.nlm.nih.gov/pubmed/3827520 - Shapiro PA.
Psychiatric aspects of cardiovascular disease. Psychiatr Clin North Am 1996; 19:613–629.
http://www.ncbi.nlm.nih.gov/pubmed/8856819 - Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT,Giardina EGV. Cardiovascular effects of bupropion in depressed
patients with heart disease. Am J Psychiatry 1991; 148:512–516.
http://www.ncbi.nlm.nih.gov/pubmed/1900980 - Roose SP, Glassman AH, Attia E, Woodring S.
Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151:1735–1739.
http://www.ncbi.nlm.nih.gov/pubmed/7977878 - Roose SP, Glassman AH, Attia E, Woodring S, Giardina EGV, Bigger JT.
Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 1998; 155:660–665.
http://www.ncbi.nlm.nih.gov/pubmed/9585718 - Roose SP, Laghrissi-Thode F, Kennedy JS, et al.
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998; 279:287–291.
http://www.ncbi.nlm.nih.gov/pubmed/9450712 - Strik JJMH, Honig A, Lousberg R, et al.
Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000; 62:783–789.
http://www.ncbi.nlm.nih.gov/pubmed/11138997 - Glassman AH, O’Connor CM, Califf RM, et al.
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288:701–709.
http://www.ncbi.nlm.nih.gov/pubmed/12169073 - Glassman AH, Bigger JT Jr, Gaffney M, Shapiro PA, Swenson JR.
Onset of major depression associated with acute coronary syndromes. Relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 2006; 63:283–288.
http://www.ncbi.nlm.nih.gov/pubmed/16520433 - Writing Committee for the ENRICHD Investigators.
Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003; 289:3106–3116.
http://www.ncbi.nlm.nih.gov/pubmed/12813116 - Lesperance F, Frasure-Smith N, Koszycki D, et al.
Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007; 297:367–379.
http://www.ncbi.nlm.nih.gov/pubmed/17244833 - Taylor CB, Youngblood ME, Catellier D, et al.
Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005; 62:792–798. http://www.ncbi.nlm.nih.gov/pubmed/15997021 - Sauer WH, Berlin JA, Kimmel SE.
Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001; 104:1894–1898.
http://www.ncbi.nlm.nih.gov/pubmed/11602490 - Sauer WH, Berlin JA, Kimmel SE.
Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 2003; 108:32–36.
http://www.ncbi.nlm.nih.gov/pubmed/12821544 - Glassman AH.
Does treating post-myocardial infarction depression reduce medical mortality? Arch Gen Psychiatry 2005; 62:711–712.
http://www.ncbi.nlm.nih.gov/pubmed/15997011 - Davidson KW, Kupfer DJ, Bigger JT, et al.
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med 2006; 68:645–650.
http://www.ncbi.nlm.nih.gov/pubmed/17012516 - Carney RM, Blumenthal JA, Freedland KE, et al.
Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004; 66:466–474.
http://www.ncbi.nlm.nih.gov/pubmed/15272090 - Xiong GL, Jiang W, Clare R, et al.
Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. Am J Cardiol 2006; 98:42–47.
http://www.ncbi.nlm.nih.gov/pubmed/16784918 - Pollock BG, Laghrissi-Thode F, Wagner WR.
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol 2000; 20:137–140.
http://www.ncbi.nlm.nih.gov/pubmed/10770450 - Serebruany VL, Glassman AH, Malinin AI, et al.
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 2003; 108:939–944.
http://www.ncbi.nlm.nih.gov/pubmed/12912814 - Shimbo D, Child J, Davidson K, et al.
Exaggerated serotoninmediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol 2002; 89:331–333.
http://www.ncbi.nlm.nih.gov/pubmed/11809437 - Kronish IM, Rieckmann N, Halm EA, et al.
Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med 2006; 21:1178–1183.
http://www.ncbi.nlm.nih.gov/pubmed/16899061 - Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE.
Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160:1818–1823.
http://www.ncbi.nlm.nih.gov/pubmed/10871976 - Rasmussen JN, Chong A, Alter DA.
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality
after acute myocardial infarction. JAMA 2007; 297:177–186.
http://www.ncbi.nlm.nih.gov/pubmed/17213401 - Rieckmann N, Gerin W, Kronish IM, et al.
Course of depressive symptoms and medication adherence after acute coronary syndromes:
an electronic medication monitoring study. J Am Coll Cardiol 2006; 48:2218–2222.
http://www.ncbi.nlm.nih.gov/pubmed/17161249 - Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA,Hilleman DE.
Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007; 131:446–452.
http://www.ncbi.nlm.nih.gov/pubmed/17296646